There is a significant global gap in cervical cancer prevention for older women. Reports from public health platforms in China and other parts of Asia reveal that large numbers of older women, especially those in rural or low-resource settings, have never participated in cervical screening programs. This gap places them at high risk for undiagnosed and advanced-stage cervical cancer, with limited treatment options and worse outcomes.

Leading Chinese medical publication Family Doctor confirms TruScreen’s efficacy as a cervical cancer screening tool for pregnant women, in a 2,000-patient study conducted at Guilin People’s Hospital.